This study aims to elucidate the potential pathway involved in the TIM3-mediated CD8+TILs exhaustion, which could provide a theoretical basis for exploring novel immunotargets of DLBCL. The gene discussed is HAVCR2; the disease is diffuse large B-cell lymphoma.